Annual ROE
-135.37%
-42.62%-45.95%
31 December 2023
Summary:
Leap Therapeutics annual return on equity is currently -135.37%, with the most recent change of -42.62% (-45.95%) on 31 December 2023. During the last 3 years, it has fallen by -12.82% (-10.46%). LPTX annual ROE is now -107.20% below its all-time high of 1881.07%, reached on 31 December 2019.LPTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-116.24%
-18.23%-18.60%
30 September 2024
Summary:
Leap Therapeutics quarterly return on equity is currently -116.24%, with the most recent change of -18.23% (-18.60%) on 30 September 2024. Over the past year, it has increased by +17.03% (+12.78%). LPTX quarterly ROE is now -128.93% below its all-time high of 401.85%, reached on 31 March 2016.LPTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.0% | +12.8% |
| 3 y3 years | -10.5% | -81.4% |
| 5 y5 years | +46.3% | +47.0% |
LPTX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -157.7% | at low | -145.3% | +18.8% |
| 5 y | 5 years | -107.2% | +46.3% | -145.3% | +71.9% |
| alltime | all time | -107.2% | +49.4% | -128.9% | +71.9% |
Leap Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -116.24%(+18.6%) |
| June 2024 | - | -98.01%(+21.0%) |
| Mar 2024 | - | -80.99%(-39.2%) |
| Dec 2023 | -135.37%(+46.0%) | -133.17%(-0.1%) |
| Sept 2023 | - | -133.27%(-2.5%) |
| June 2023 | - | -136.66%(-4.5%) |
| Mar 2023 | - | -143.12%(+103.7%) |
| Dec 2022 | -92.75%(+76.6%) | -70.26%(+18.6%) |
| Sept 2022 | - | -59.23%(+22.0%) |
| June 2022 | - | -48.53%(+2.4%) |
| Mar 2022 | - | -47.38%(-20.7%) |
| Dec 2021 | -52.53%(-57.1%) | -59.75%(-6.8%) |
| Sept 2021 | - | -64.08%(-10.0%) |
| June 2021 | - | -71.18%(+4.5%) |
| Mar 2021 | - | -68.14%(-13.0%) |
| Dec 2020 | -122.55%(-106.5%) | -78.28%(-12.3%) |
| Sept 2020 | - | -89.24%(-38.7%) |
| June 2020 | - | -145.64%(-62.2%) |
| Mar 2020 | - | -385.47%(-6.8%) |
| Dec 2019 | 1881.07% | -413.63%(+88.7%) |
| Sept 2019 | - | -219.22%(+8.5%) |
| June 2019 | - | -201.99%(+7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -187.72%(-10.6%) |
| Dec 2018 | -252.19%(-5.7%) | -210.03%(-22.6%) |
| Sept 2018 | - | -271.35%(+10.1%) |
| June 2018 | - | -246.40%(+13.9%) |
| Mar 2018 | - | -216.40%(+18.7%) |
| Dec 2017 | -267.40%(-1145.8%) | -182.32%(-172.8%) |
| Sept 2017 | - | 250.30%(+64.2%) |
| June 2017 | - | 152.45%(-13.3%) |
| Mar 2017 | - | 175.82%(+157.9%) |
| Dec 2016 | 25.57%(+49.2%) | 68.18%(+22.9%) |
| Sept 2016 | - | 55.46%(-72.4%) |
| June 2016 | - | 201.18%(-49.9%) |
| Mar 2016 | - | 401.85%(-368.5%) |
| Dec 2015 | 17.14%(-131.1%) | -149.64%(+106.1%) |
| Sept 2015 | - | -72.61%(+0.8%) |
| June 2015 | - | -72.02%(-6.1%) |
| Mar 2015 | - | -76.70%(-4.6%) |
| Dec 2014 | -55.08%(-43.6%) | -80.42%(-8.2%) |
| Sept 2014 | - | -87.62%(-38.9%) |
| June 2014 | - | -143.35%(+23.8%) |
| Mar 2014 | - | -115.82%(+18.6%) |
| Dec 2013 | -97.64%(+64.9%) | -97.64% |
| Dec 2012 | -59.22% | - |
FAQ
- What is Leap Therapeutics annual return on equity?
- What is the all time high annual ROE for Leap Therapeutics?
- What is Leap Therapeutics annual ROE year-on-year change?
- What is Leap Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Leap Therapeutics?
- What is Leap Therapeutics quarterly ROE year-on-year change?
What is Leap Therapeutics annual return on equity?
The current annual ROE of LPTX is -135.37%
What is the all time high annual ROE for Leap Therapeutics?
Leap Therapeutics all-time high annual return on equity is 1881.07%
What is Leap Therapeutics annual ROE year-on-year change?
Over the past year, LPTX annual return on equity has changed by -42.62% (-45.95%)
What is Leap Therapeutics quarterly return on equity?
The current quarterly ROE of LPTX is -116.24%
What is the all time high quarterly ROE for Leap Therapeutics?
Leap Therapeutics all-time high quarterly return on equity is 401.85%
What is Leap Therapeutics quarterly ROE year-on-year change?
Over the past year, LPTX quarterly return on equity has changed by +17.03% (+12.78%)